Kura Oncology: Is Being Furnished And Shall Not Be Deemed To Be Filed For The Purposes Of Section 18 Of The Securities And Exchange Act Of 1934, As Amended (the Exchange Act ), Or Otherwise Subject To The Liabilities Of That Section And Will Not Be Incorporated By Reference Into Any Filing By The Company Under The Securities Act Of 1933, As Amended, Or The Exchange Act, Unless Specifically Identified As Being Incorporated Therein By Reference, Other Events, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Kura Oncology Inc
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***